What Very Bad Plastic Surgery Looks Like in 2024 Data
Very bad plastic surgery refers to procedures with severe complications, revision surgeries, or outcomes that require additional medical intervention. The American Society of Plastic Surgeons (ASPS) reported over 250,000 revision procedures in the latest annual tracking year, with a significant share tied to unsatisfactory initial results from minimally invasive and surgical aesthetics. The average cost of a revision rhinoplasty in the U.S. ranges from $7,000 to $15,000, and a breast implant removal or replacement can exceed $10,000, according to data compiled by the Aesthetic Surgery Journal and industry cost surveys. These figures do not include lost wages, travel, or psychological support, which can push total financial exposure well beyond the procedure price. Forbes analysis of hidden costs.
Common Procedures Linked to Very Bad Outcomes
rhinoplasty, breast augmentation, liposuction, and injectable filler complications dominate reports of very bad plastic surgery. The ASPS data shows that rhinoplasty consistently ranks among the top three procedures requiring revision, with rates influenced by surgeon specialization, patient selection, and technique choice. Injectable complications, including vascular occlusion and tissue necrosis, have risen with the expansion of non-surgical aesthetics, and the Aesthetic Surgery Journal notes that filler-related interventions now represent a growing share of revision case volume. FDA device oversight page.
Financial and Market Impact of Very Bad Plastic Surgery
Very bad plastic surgery creates measurable financial ripple effects for patients, clinics, and insurers. Out-of-pocket spending on revision procedures in the U.S. is estimated in the billions annually, with most costs borne directly by patients because many initial procedures are financed through private payment plans rather than insurance. The rise of medical tourism for low-cost surgery has increased the volume of international patients seeking revisions in the U.S., adding logistical and legal complexity to an already expensive process. SEC filings on medical device companies show that publicly traded device makers track implant-related revision volumes as a key risk factor.
How Bad Outcomes Affect Clinic Revenue and Reputation
Clinics facing a high rate of very bad plastic surgery cases experience reputational damage, increased malpractice risk, and potential loss of board certification standing. The American Board of Plastic Surgery tracks board-certified surgeon outcomes, and practices with elevated complication rates may face stricter peer review and reduced referral volumes. Insurance payers and third-party administrators increasingly use complication data to adjust coverage policies, which can shift costs back to patients and independent surgeons. Forbes notes that clinic marketing budgets now allocate significant spend to managing online reviews tied to revision cases.
Regulation, Safety Standards, and Consumer Protection
Federal and state regulators oversee devices, drugs, and facility standards related to very bad plastic surgery outcomes. The FDA clears or approves implants, fillers, and energy-based devices, and post-market surveillance data feeds into safety communications that directly affect practice protocols. State medical boards enforce licensing, advertising rules, and malpractice reporting, and they can discipline surgeons whose very bad plastic surgery outcomes suggest patterns of negligence or inadequate informed consent. FDA plastic surgery device page.